Company Filing History:
3 out of 61 
3 out of 12 Years Active: 2024-2025
Title: **Krzysztof Kaminski: Innovator in Neurological Treatment**
Introduction
Krzysztof Kaminski is a notable inventor based in Cracow, Poland, recognized for his significant contributions to the field of neuroscience through innovative pharmaceutical compounds. His work primarily focuses on developing modified amino acid derivatives aimed at treating various neurological diseases and psychiatric disorders.
Latest Patents
Kaminski holds two patents that showcase his groundbreaking research. His first patent discusses modified amino acid derivatives designed for the treatment of neurological diseases and selected psychiatric disorders. The compounds include 2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2-oxopyrrolidin-1-yl)propanamide derivatives with R-configuration at the stereogenic center. These derivatives demonstrate broad-spectrum protective activity in animal models of epileptic seizures, pain, depression, and anxiety, all while avoiding undesirable sedative effects. Furthermore, they exhibit neuroprotective effects in both in vitro and in vivo studies.
His second patent involves (2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide derivatives and their application in treating neurological diseases. The patent outlines the compound of general formula (I) and its pharmaceutically acceptable salts, proposing its use as an active ingredient in pharmaceutical compositions for treating conditions such as epileptic seizures, neuropathic pain, and migraines.
Career Highlights
Krzysztof Kaminski has made remarkable strides in his career, particularly in the academic sphere. He has worked at prestigious institutions, including Jagiellonian University and Warsaw Medical University, where he has contributed to research that enhances our understanding of neurological disorders.
Collaborations
Throughout his career, Kaminski has collaborated with talented professionals, including Michal Abram and Anna Rapacz. These collaborations have facilitated the sharing of knowledge and expertise, further advancing his research endeavors and fostering innovation in the field.
Conclusion
Krzysztof Kaminski exemplifies the spirit of innovation, particularly in the development of treatments for neurological and psychiatric conditions. His patents not only underscore his dedication to advancing medical science but also contribute valuable solutions for patients suffering from these challenging disorders.